August 5, 2021
$4.8 Million Awarded to Develop Treatment for Bartonella-Related Disease
The CVM is leading the way to develop an effective antimicrobial treatment for animals and humans impacted by the Bartonella family of bacteria.
April 8, 2021
Pilot Study Finds Evidence of Bartonella Infection in Schizophrenia Patients
Bartonella are bacteria historically associated with cat-scratch disease, which until recently was thought to be solely a short-lived or self-limiting infection.